
Stryker Corporation (SYK) – Strong demand for ‘Mako’ leading performance
in Company Report , Healthcare & Life Sciences , Pharma & Biotech on September 20, 2023Stryker Corporation (SYK) (Q2FY23)
Stock Performance – Stryker Corporation stock price showed a volatile trend in the past 3-month period. It gave 4.43% returns during the period. The stock price increased by 31.21% in the past 1 year. The stock has a 52-week high of $306.93 and its 52-week low is $200.80.
In the past 3 years, the stock has given returns of 44.45%. SYK has a 50-day moving Avg. and 200-day moving Avg. of $287.46 and $274.20, respectively.
Quarter Performance: SYK net sales increased 11.2% in the three months 2023 as reported and 11.9% in constant currency, as foreign currency exchange rates negatively impacted net sales by 0.7%. Net sales in constant currency increased by 11.4% from increased unit volume and 0.5% due to higher prices.
Company Guidance for FY23 – SYK expect organic net sales growth to be in the range of 9.5% to 10.5% including slightly positive pricing for the year. If foreign exchange rates hold near their current levels, the company anticipate that net sales will be unfavorably impacted by 0.3% and adjusted net earnings per diluted share will be unfavorably impacted by $0.05 to $0.10 for FY23
Highlights
Stryker’s commitment to customer support and innovation positions it well for growth as the pandemic’s impact diminishes. In Q2FY23, the company allocated 6.4% of net sales to adjusted research and development expenses, underscoring its dedication to innovation. This investment is expected to drive the launch of new products in the future.
This report is useful for M&A, business & investment analysis to all students, researchers, investors, private equity houses, broking firms, hedge funds, advisory firms and corporates to decide upon their investment strategies. Do connect with us, if you are looking for equity valuation, recommendation, analysis and market recommendation for any specific company, sector and industry.
Highlights
Valuation
– Enterprise Value
– CrispIdea Forecast
– CrispIdea Segment Forecast
– Economic Value Added Analysis
– Discounted Cash Flow Analysis
– PE Band Comparison
– Peer Valuation
– CrispIdea Forecast Relative to Consensus
– Consensus History and Surprise
– Consensus Momentum
Actual & Historical Performance
– Income Statement
– Balance Sheet
– Cash Flow
– 10 Year Historical Performance
– Ratio Analysis
– Du Pont Analysis
– ROIC & ROCE Analysis
– Segment Performance
– M&A Deals
Peer Performance
– Summary
– Profitability
– Growth
– Price Performance
Ownership
Stock Price Performance
Crispidea Coverage
No of Pages: 36
To download the previous quarter’s equity/report CLICK HERE
To Download other equity/reports CLICK HERE
Follow our LinkedIn page for more updates.